List of Studies ( Metabolite:6-Methyltetrahydropterin)
Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
---|---|---|---|---|---|---|---|
ST001680 | AN002739 | Metabolome of NAFLD in high fat diet mouse model | Liver | Mouse | Fatty liver disease | Weill Cornell Medicine | Abundance |
ST002759 | AN004481 | Metabolic responses of normal rat kidneys to a high salt intake (Kidney cortex) | Kidney cortex | Rat | Medical College of Wisconsin | Area | |
ST003087 | AN005048 | Metabolome changes in embryonic CSF (Part 9) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | a.u. |
ST003089 | AN005052 | Metabolome changes in embryonic CSF (Part 11) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | a.u. |
ST002551 | AN004200 | Metabolomics dataset of CNTF induced axon regeneration in mice post optic nerve crush | Eye tissue | Mouse | Eye disease | University of Miami | µg/ml |
ST002111 | AN003454 | Metabolomics dataset of optogenetic axon regenerative mouse model post optic nerve crush | Eye tissue | Mouse | Eye disease | University of Miami | µg/mL |
ST002775 | AN004517 | Zebrafish Retina Regeneration Metabolomics - 3 Days Post Crush | Eye tissue | Zebrafish | Eye disease | University of Miami | Normalized Concentrations |
ST003278 | AN005369 | Metabolomic analysis of Axon Regeneration in Xenopus laevis Retina | Eye tissue | Frog | Eye disease | University of Miami | Peak area |
ST003279 | AN005371 | Metabolomic analysis of Axon Regeneration in Xenopus laevis Tectum | Eye tissue | Frog | Eye disease | University of Miami | Peak area |
ST003280 | AN005373 | Metabolomic analysis of Axon Regeneration in Xenopus laevis Optic Nerve | Eye tissue | Frog | Eye disease | University of Miami | Peak area |
ST002776 | AN004519 | Zebrafish Optic Nerve Regeneration, Tectum Metabolomics - 3 Days Post Crush | Eye tissue | Zebrafish | Eye disease | University of Miami | Peak Area |
ST002066 | AN003365 | Glutaminase inhibition impairs CD8 T cell activation in STK11/Lkb1 deficient lung cancer | Lung | Mouse | Cancer | The Walter and Eliza Hall Institute of Medical Research | peak height |
ST003036 | AN004977 | Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 2 | Bacterial cells | Pseudomonas aeruginosa | Bacterial infection | Monash Institute of Pharmaceutical Sciences | peak height |
ST003179 | AN005221 | Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4 | Plasmodium cells | Plasmodium falciparum | Malaria | Monash University | Peak height |
ST000421 | AN000663 | ms3076 T1D poor glycemic control and control samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
ST000549 | AN000837 | Investigating large scale metabolomics in mice serum lacking insulin receptors and IGF-1 receptors | Blood | Mouse | Diabetes | Mayo Clinic | Peak intensity |
ST000566 | AN000870 | Large Scale C18 Profiling of the Effects of Curcumin Supplementation of Older Adults: Relation to Vascular Function | Blood | Human | Heart disease | Mayo Clinic | Peak intensity |
ST000567 | AN000872 | Large Scale HILIC Profiling of the Effects of Curcumin Supplementation of Older Adults: Relation to Vascular Function | Blood | Human | Heart disease | Mayo Clinic | Peak intensity |
ST001202 | AN002000 | Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | Peak intensity |
ST001202 | AN002000 | Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | Peak intensity |
ST001204 | AN002004 | Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | Peak intensity |
ST001204 | AN002004 | Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | Peak intensity |
ST001205 | AN002006 | Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | Peak intensity |
ST001205 | AN002006 | Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | Peak intensity |
ST002094 | AN003421 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | raw intensity |
ST000046 | AN000076 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
ST000046 | AN000077 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
ST000047 | AN000080 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
ST002108 | AN003448 | Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3) | Blood | Plasmodium falciparum | Malaria | Monash University | relative intensity |